Oncology Industry Trends: A 2025 Retrospective

, ,
In this article, we review some of the major trends in oncology drug development in 2025 through the lens of recent FDA drug approvals. The future for biologics, non-animal models, and AI integration are discussed.

Expert Insights: Navigating the Evolving Landscape of Preclinical Oncology

, ,
Dr. Jenny Worthington, Managing Director of Axis Bioservices, discusses the present and future of preclinical oncology, and how to choose the 'right' models to test drugs targeting a disease as complex as cancer.